Literature DB >> 17522379

Ser170 controls the conformational multiplicity of the loop 166-175 in prion proteins: implication for conversion and species barrier.

Alemayehu A Gorfe1, Amedeo Caflisch.   

Abstract

The self-perpetuating conversion of cellular prion proteins (PrP(C)) into an aggregated beta-sheet rich conformation is associated with transmissible spongiform encephalopathies (TSE). The loop 166-175 (L1) in PrP(C), which displays sequence and structural variation among species, has been suggested to play a role in species barrier, in particular against transmission of TSE from cervids to domestic and laboratory animals. L1 is ordered in elk PrP, as well as in a mouse/elk hybrid (in which L1 of mouse is replaced by elk) but not in other species such as mice, humans, and bovine. To investigate the source and significance of L1 dynamics, we carried out explicit solvent molecular dynamics simulations (approximately 0.5 micros in total) of the mouse prion protein, the mouse/elk hybrid, and control simulations, in which the mouse sequence is reintroduced into the structure of the mouse/elk hybrid. We found that the flexibility of L1 correlates with the backbone dynamics of Ser170. Furthermore, L1 mobility promotes a substantial displacement of Tyr169, rupture of the Asp178-Tyr128 and Asp178-Tyr169 side chain hydrogen bonds, as well as disruption of Tyr169-Phe175 pi-stacking interaction. The simulation results go beyond the available experimental data because they highlight the dependence of this network of interactions on residue 170 and L1 plasticity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522379     DOI: 10.1096/fj.07-8292com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  18 in total

1.  Disruption of the X-loop turn of the prion protein linked to scrapie resistance.

Authors:  Alexander D Scouras; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2012-03-23       Impact factor: 1.650

2.  Optimal molecular structures of prion AGAAAAGA amyloid fibrils formatted by simulated annealing.

Authors:  Jiapu Zhang
Journal:  J Mol Model       Date:  2010-04-22       Impact factor: 1.810

Review 3.  A brief history of prions.

Authors:  Mark D Zabel; Crystal Reid
Journal:  Pathog Dis       Date:  2015-10-07       Impact factor: 3.166

4.  Constraining the loop, releasing prion infectivity.

Authors:  Claudio Soto
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-31       Impact factor: 11.205

5.  Structural plasticity of the cellular prion protein and implications in health and disease.

Authors:  Barbara Christen; Fred F Damberger; Daniel R Pérez; Simone Hornemann; Kurt Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

6.  Prion protein β2-α2 loop conformational landscape.

Authors:  Enrico Caldarulo; Alessandro Barducci; Kurt Wüthrich; Michele Parrinello
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

7.  The roles of the conserved tyrosine in the β2-α2 loop of the prion protein.

Authors:  Danzhi Huang; Amedeo Caflisch
Journal:  Prion       Date:  2015       Impact factor: 3.931

8.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Mathias Heikenwalder; Giuseppe Manco; Petra Schwarz; David Ott; Thomas Rülicke; Pawel P Liberski; Christian Julius; Jeppe Falsig; Lothar Stitz; Kurt Wüthrich; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

9.  The effect of β2-α2 loop mutation on amyloidogenic properties of the prion protein.

Authors:  Arpana Dutta; Shugui Chen; Witold K Surewicz
Journal:  FEBS Lett       Date:  2013-07-24       Impact factor: 4.124

10.  Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1.

Authors:  Michele L Kadnar; Gulnara Articov; Irina L Derkatch
Journal:  PLoS Genet       Date:  2010-01-22       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.